Biological company Eyenovia launches HYPE treasury reserve strategy, investing $50 million

律动BlockBeats|Jun 17, 2025 19:06
BlockBeats News: On June 18th, according to market reports, Eyenovia, a clinical stage ophthalmic biopharmaceutical company, announced that it will invest $50 million to launch the Hyperliquid (HYPE) treasury reserve strategy.
Share To
Timeline
HotFlash
APP
X
Telegram
CopyLink